PureTech Health (PRTC) Retained Earnings (2019 - 2025)
PureTech Health (PRTC) reported Retained Earnings of -$77.2 million for Q4 2025, down 1534.17% year-over-year from $5.4 million in Q4 2024, and down 7796.83% on a QoQ basis from -$978000.0 in Q2 2025.
PureTech Health (PRTC) has 6 years of Retained Earnings data on file, last reported at -$77.2 million in Q4 2025.
- Quarterly Retained Earnings fell 1534.17% year-over-year to -$77.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$77.2 million (down 1534.17% YoY) and the FY2025 annual result came in at -$77.2 million, down 1534.17% from the prior year.
- Retained Earnings slipped to -$77.2 million in Q4 2025 per PRTC's latest filing, from -$978000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $149.5 million in Q4 2022 and bottomed at -$77.2 million in Q4 2025.
- The 4-year median for Retained Earnings is -$4.7 million (2024), against an average of $5.3 million.
- The widest annual swing landed in 2022, when Retained Earnings surged 473.07%; it then tumbled 1534.17% in 2025.
- Tracing PRTC's Retained Earnings over 4 years: stood at -$40.1 million in 2021, then surged by 473.07% to $149.5 million in 2022, then slumped by 103.16% to -$4.7 million in 2024, then plunged by 1534.17% to -$77.2 million in 2025.
- Per Business Quant, the three latest PRTC Retained Earnings figures stand at -$77.2 million (Q4 2025), -$978000.0 (Q2 2025), and -$4.7 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | -77.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77.23 Mn |
| Jun 30, 2025 | -978,000.00 |
| Dec 31, 2024 | -4.73 Mn |
| Dec 31, 2022 | 149.52 Mn |
| Dec 31, 2021 | -40.08 Mn |
| Dec 31, 2020 | 260.43 Mn |
| Dec 31, 2019 | -18.28 Mn |